Try our Advanced Search for more refined results
October 12, 2016
Astellas Pharma Inc. et al v. Windlas Healthcare Pvt. Ltd.
Case Number:
1:16-cv-00930
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 07, 2020
Astellas, Indian Generic Cos. Settle IP Fight Over Bladder Drug
Astellas Pharma Inc. has recently reached settlements with a pair of Indian drugmakers that are aiming to make generic versions of its patent-protected overactive bladder treatment Myrbetriq.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login